Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03A ADRENERGICS, INHALANTS
R03AL Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids
R03AL04 Indacaterol and glycopyrronium bromide
D10505 Glycopyrronium bromide and indacaterol maleate <JP>
USP drug classification [BR:br08302]
Respiratory Tract/Pulmonary Agents
Bronchodilator Combinations
Indacaterol/ Glycopyrrolate
D10505 Glycopyrronium bromide and indacaterol maleate
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
22 Respiratory organ agents
225 Bronchodilators
2259 Others
D10505 Glycopyrronium bromide and indacaterol maleate
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D10505 Glycopyrronium bromide and indacaterol maleate
Transporter substrate
DG01665 ABCB1 substrate
D10505 Glycopyrronium bromide and indacaterol maleate
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D10505
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D10505
Drug transporters
D10505
